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Heart, Lung, and Blood Institute (historical
article), 615
Neointimal hyperplasia
External beam radiation after stent implantation
increases neointimal hyperplasia by
augmenting smooth muscle cell proliferation
and extracellular matrix accumulation, 561
Nesiritide
Sustained hemodynamic effects of an infusion of
nesiritide (human type natriuretic peptide) in
heart failure: a randomized, double-blind,
placebo-controlled clinical trial, 155
Neuroendocrine system
Hemodynamic and neuroendocrine effects for
Candoxatril and frusemide in mild stable
chronic heart failure, 1794
Neuroendocrine activation in heart failure is
modified by endurance exercise training, 1170
Neutrophil activation
P-selectin inhibition prevents early neutrophil
activation but provides only modest protection
against myocardial injury in dogs with isch-
emia and forty-eight hours reperfusion, 280
Nicotine
See also Smoking
Smokeless tobacco as a possible risk factor for
myocardial infarction: a population-based
study in middle-aged men, 1784
Nitric oxide
Abnormal cardiac function in the streptozotocin-
induced non–insulin-dependent diabetic rat:
noninvasive assessment with Doppler
echocardiography and contribution of the
nitric oxide pathway, 2110
Gene transfer of nitric oxide synthase: effects on
endothelial biology, 1201
Glutathione reverses endothelial dysfunction and
improves nitric oxide bioavailability, 507
Nitroglycerin
Coronary artery distensibility in diabetic patients
with simultaneous measurements of luminal
area and intracoronary pressure: evidence of
impaired reactivity to nitroglycerin, 1075
Nuclear cardiology
Nuclear cardiology after angioplasty and stent
placement: beyond sensitivity and specificity
(editorial comment), 1042
Occlusion
See Coronary occlusion
Operator volume
Direct coronary stenting without predilation, 1916
Percutaneous coronary interventions heed the
American College of Cardiology volume
recommendations, but strive to improve
quality (editorial comment), 1481
Relationship between operator volume and
outcomes after percutaneous coronary
interventions in high volume hospitals in
1994–1996, the northern New England
experience, 1471
Outcome analysis
Outcome of Hispanic patients treated with
thrombolytic therapy for acute myocardial in-
farction: results from the GUSTO-I and -III
trials, 1729
Oxygen consumption
Myocardial perfusion and oxygen consumption in
reperfused noninfarcted dysfunctional
myocardium after unstable angina: direct
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evidence for myocardial stunning in humans,
1939
Oxygen consumption of the heart: newer concepts
of its multifactorial determination (historical
article), 1365
P-selectin
P-selectin inhibition prevents early neutrophil
activation but provides only modest protection
against myocardial injury in dogs with isch-
emia and forty-eight hours reperfusion, 280
Risk stratification of emergency department
patients with acute coronary syndromes using
P-selectin, 95
Pacing
Comparison of dual-chamber pacing versus septal
myectomy for the treatment of patients with
hypertrophic obstructive cardiomyopathy: a
comparison of objective hemodynamic and
exercise end-points, 191
Demonstration of the mechanisms of transient
entrainment and interruption of ventricular
tachycardia with rapid atrial pacing (historical
article), 959
Electromechanical left ventricular behavior after
nonsurgical septal reduction in patients with
hypertrophic obstructive cardiomyopathy,
1117
Elevated endothelin concentrations are associated
with reduced coronary vasomotor responses in
patients with chest pain and normal coronary
arteriograms, 455
Pain
Effect of acetylsalicylate on cardiac and muscular
pain induced by intracoronary and intra-
arterial infusion of bradykinin in humans, 216
Parasympathetic nervous system
Ventricular rate control during atrial fibrillation by
cardiac parasympathetic nerve stimulation: a
transvenous approach, 2042
Patient care
President’s page: great circle: a target for better
patient care, 294
Payment issues
President’s page: what is advocacy doing for us?
What can we do?, 607
Pediatric cardiology
See also Congenital heart defects; Surgery, pediatric
Cohort study of childhood hypertrophic
cardiomyopathy: improved survival following
high-dose beta-adrenoceptor antagonist
treatment, 1813
Complications of endomyocardial biopsy in
children, 2105
Detection of viral genotypes by polymerase chain
reaction in the myocardium of pediatric
patients with advanced HIV disease, 857
Milking in hypertrophic cardiomyopathy (letter),
949
Training programs in the United States, in adult
cardiology, pediatric cardiology, and
cardiothoracic surgery, and post-fellowship
training (Preceptorships) in adult cardiology,
1231
Percutaneous coronary interventions
See also specific procedure
Changing outcomes in percutaneous coronary
interventions: a study of 34,752 procedures in
northern New England, 674
Creatine kinase-MB elevation after coronary
intervention correlates with diffuse
atherosclerosis, and low-to-medium level
elevation has a benign clinical course:
implications for early discharge after coronary
intervention, 663
Elevation of creatine kinase, MB fraction after
elective coronary intervention: a valid
surrogate end point of poor late outcome?
(editorial comment), 672
Multivariate prediction of in-hospital mortality after
percutaneous coronary interventions in 1994–
1996, 681
Percutaneous coronary interventions heed the
American College of Cardiology volume
recommendations, but strive to improve
quality (editorial comment), 1481
Relationship between operator volume and
outcomes after percutaneous coronary
interventions in high volume hospitals in
1994–1996, the northern New England
experience, 1471
Performance management and measures
President’s page: performance measures and our
“art,” 1229
Perfusion
See Myocardial perfusion
Peripheral vascular disease
Prognostic importance of lower extremity arterial
disease in patients undergoing coronary
revascularization in the Bypass Angioplasty
Revascularization Investigation (BARI), 716
Phen-fen
See Phentermine-fenfluramine
Phentermine-fenfluramine
Fen-Phen and valvular heart disease: if it sounds
too bad to be true, perhaps it isn’t (editorial
comment), 1159
Low prevalence of valvular heart disease in 226
phentermine-fenfluramine protocol subjects
prospectively followed for up to 30 months,
1153
Phenylephrine
Deletion genotype of the angiotensin I-converting
enzyme is associated with an increased
vascular reactivity in vivo and in vitro, 830
Noninvasive assessment of the cardiac baroreflex
response to downward tilting and comparison
with the phenylephrine method, 211
Photoplethysmography
Photoplethysmographic assessment of pulse wave
reflection: blunted response to endothelium-
dependent beta2-adrenergic vasodilation in
type II diabetes mellitus, 2007
Plasma tissue factor
Angiotensin-converting enzyme inhibition reduces
monocyte chemoattractant protein-1 and
tissue factor levels in patients with myocardial
infarction, 983
Plasminogen activator
Myoglobin, creatine kinase-MB and cardiac
troponin I 60-minute ratios predict infarct-
related artery patency after thrombolysis for
acute myocardial infarction: results from the
Thrombolysis in Myocardial Infarction study
(TIMI) 10B, 739
Plasminogen activator inhibitor
Angiotensin I-converting enzyme and plasminogen
activator inhibitor-1 gene variants: risk of
mortality and fatal cardiovascular disease in an
elderly population-based cohort, 1176
Lack of association of a common polymorphism of
the plasminogen activator inhibitor-1 gene
with coronary artery disease and myocardial
infarction, 1778
Platelet
Effect of glycoprotein IIb/IIIa receptor blockade on
platelet-leukocyte interaction and surface
expression of the leukocyte integrin Mac-1 in
acute myocardial infarction, 1420
Platelet activation
Changes of hemostasis, endogenous fibrinolysis,
platelet activation and endothelins after
percutaneous transluminal coronary
angioplasty in patients with stable angina, 486
Platelet aggregation
Differential effects of a- and g-tocopherol on low-
density lipoprotein oxidation, superoxide
activity, platelet aggregation and arterial
thrombogenesis, 1208
Polymerase chain reaction
Detection of viral genotypes by polymerase chain
reaction in the myocardium of pediatric
patients with advanced HIV disease, 857
Potassium channel defects
Sinus node function and ventricular repolarization
during exercise stress test in long QT
syndrome patients with KvLQT1 and HERG
potassium channel defects, 823
Practice guidelines
See also ACC/AHA Practice Guidelines
Clinical practice guidelines in unstable angina
improves clinical outcomes by assuring early
intensive medical treatment, 1689
Practice issues
President’s page: what is advocacy doing for us?
What can we do?, 607
Pravastatin
Pravastatin prevents clinical events in revascularized
patients with average cholesterol concentrations,
106
Pravastatin restored the infarct size-limiting effect
of ischemic preconditioning blunted by
hypercholesterolemia in the rabbit model of
myocardial infarction, 2120
Preceptorships
Training programs in the United States, in adult
cardiology, pediatric cardiology, and
cardiothoracic surgery, and post-fellowship
training (Preceptorships) in adult cardiology,
1231
Preconditioning
Bradykinin-induced preconditioning in patients
undergoing coronary angioplasty, 639
Evidence for the delayed effect of human ischemic
preconditioning: prospective multicenter study
for preconditioning in acute myocardial infarc-
tion, 1966
Pravastatin restored the infarct size-limiting effect
of ischemic preconditioning blunted by
hypercholesterolemia in the rabbit model of
myocardial infarction, 2120
Pregnancy
Intravenous immune globulin in the therapy of
peripartum cardiomyopathy, 177
Pressure
See Ventricular pressure decay time
Preventive care
Relative influence of secondary versus primary
prevention using the National Cholesterol
Education Program Adult Treatment Panel II
guidelines, 768
Primary care centers
Remote telemedical interpretation of neonatal
echocardiograms: impact on clinical
management in a primary care setting, 241
Prognosis
Comparison of troponin T and troponin I as
predictors of cardiac events in patients
undergoing chronic dialysis at a Veteran’s
hospital: a pilot study, 448
One-year follow-up after intravascular ultrasound
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assessment of moderate left main coronary
artery disease in patients with ambiguous
angiograms, 707
Prediction of cardiac events after uncomplicated
acute myocardial infarction by clinical
variables and dobutamine stress test, 435
Prognostic importance of lower extremity arterial
disease in patients undergoing coronary
revascularization in the Bypass Angioplasty
Revascularization Investigation (BARI), 716
Prostacyclin
Effect of orally active prostacyclin analogue on
survival of outpatients with primary
pulmonary hypertension, 1188
Effects of chronic prostacyclin therapy on cardiac
output and symptoms in primary pulmonary
hypertension, 1184
Pulmonary artery banding
New strategy for the surgical treatment of aortic
coarctation associated with ventricular septal
defect in infants using an absorbable
pulmonary artery band, 866
Pulmonary capillary wedge pressure
Combined use of pulsed and color M-mode Dopp-
ler echocardiography for the estimation of
pulmonary capillary wedge pressure: an
empirical approach based on an analytical
relation, 515
Noninvasive evaluation of pulmonary capillary
wedge pressure in patients with acute
myocardial infarction by deceleration time of
pulmonary venous flow velocity in diastole, 90
Pulmonary edema
Long T wave inversion and QT prolongation
associated with pulmonary edema: a report of
nine cases, 1106
Pulmonary vascular disease
Hypoplastic left heart syndrome with intact atrial
septum: atrial morphology, pulmonary
vascular histopathology and outcome, 554
Pulmonary vein
Noninvasive assessment of left atrial maximum
dP/dt by a combination of transmitral and
pulmonary venous flow, 795
Pulmonary venous systolic flow pulse—its origin
and relationship to left atrial pressure, 802
QT interval
Exaggerated QT prolongation after cardioversion of
atrial fibrillation, 396
Long T wave inversion and QT prolongation
associated with pulmonary edema: a report of
nine cases, 1106
Sinus node function and ventricular repolarization
during exercise stress test in long QT
syndrome patients with KvLQT1 and HERG
potassium channel defects, 823
Quality assessment
Assessing the quality of medical diagnosis (editorial
comment), 1837
Epidemiologic approach to quality assessment in
echocardiography diagnosis, 1831
Quinapril
Effect of angiotensin-converting enzyme inhibition
and angiotensin II type-I receptor antagonism
on postprandial endothelial function, 140
Quinaprilat
Improvement of myocardial blood flow to ischemic
regions by angiotensin-converting enzyme
inhibition with quinaprilat IV: a study using
[15O] water dobutamine stress positron
emission tomography, 1005
QW7437
Flow dynamics of QW7437, a new
dodecafluoropentane ultrasound contrast
agent, in the microcirculation: microvascular
mechanisms for persistent tissue echo
enhancement, 578
Race factors
Association of body mass, gender and race with
heart failure primarily due to hypertension, 1602
Racial differences in the significance of coronary
calcium in asymptomatic black and white
subjects with coronary risk factors, 787
Radial artery
Use of radial artery applanation tonometry (letter),
951
Radiation therapy
External beam radiation after stent implantation
increases neointimal hyperplasia by
augmenting smooth muscle cell proliferation
and extracellular matrix accumulation, 561
Vascular radiation therapy: the devil is in the dose
(editorial comment), 567
Randomized trials
See also Clinical trials
Final results of the STent versus Directional
Coronary Atherectomy Randomized Trial
(START), 1050
When should we start randomized trials for new
devices? (editorial comment), 1049
Reader bias
Epidemiologic approach to quality assessment in
echocardiography diagnosis, 1831
Reentry circuits
Characteristics of electrograms recorded at reentry
circuit sites and bystanders during ventricular
tachycardia after myocardial infarction, 381
Reperfusion
Cardiomyocytes from hearts with left ventricular
dysfunction after ischemia-reperfusion do not
manifest contractile abnormalities, 594
Reperfusion injury
P-selectin inhibition prevents early neutrophil
activation but provides only modest protection
against myocardial injury in dogs with isch-
emia and forty-eight hours reperfusion, 280
Reperfusion therapy
Long-term (three-year) prognosis of patients
treated with reperfusion or conservatively after
myocardial infarction, 70
Research
Cause of death in clinical research: time for a
reassessment? (viewpoint), 618
Measurement of heart rate variability: a clinical tool
or a research toy?, 1878
Restenosis
External beam radiation after stent implantation
increases neointimal hyperplasia by
augmenting smooth muscle cell proliferation
and extracellular matrix accumulation, 561
Is redo percutaneous mitral balloon valvuloplasty
(PMV) indicated in patients with post-PMV
mitral restenosis?, 49
Laser angioplasty of restenosed coronary stents:
results of a multicenter surveillance trial, 25
Long lesions, long stents and the long process of
stent optimization (editorial comment), 660
Mechanisms of acute lumen gain and recurrent re-
stenosis after rotational atherectomy of diffuse
in-stent restenosis: a quantitative angiographic
and intravascular ultrasound study, 33
Periprocedural quantitative coronary angiography
after Palmaz-Schatz stent implantation
predicts the restenosis rate at six months:
results of a metaanalysis the Belgian
Netherlands Stent Study (BENESTENT) I,
BENESTENT II Pilot, BENESTENT II
and MUSIC Trials, 1067
Preprocedural serum levels of C-reactive protein
predicts early complications and late restenosis
after coronary angioplasty, 1512
Propensity and mechanisms of restenosis in
different coronary stent designs:
complementary value of the analysis of the
luminal gain-loss relationship, 1490
Randomized comparison of coronary stent
implantation and balloon angioplasty in the
treatment of de novo coronary artery lesions
(START): a four-year follow-up, 1498
Randomized trial of elective stenting after balloon
recanalization of chronic total occlusions, 722
Restenosis, late vessel occlusion and left ventricular
function six months after balloon angioplasty
in diabetic patients, 476
Short- and long-term evolution of unstented
nonocclusive coronary dissection after
coronary angioplasty, 1484
Stented segment length as an independent predictor
of restenosis, 651
Tissue characteristics of restenosis after
percutaneous transluminal coronary
angioplasty in diabetic patients, 1045
Vascular radiation therapy: the devil is in the dose
(editorial comment), 567
Revascularization
See also specific procedure
Cardiac troponin I levels and clinical outcomes
in patients with acute coronary syndromes:
the potential role of early percutaneous
revascularization, 1704
Catheter-based percutaneous myocardial laser
revascularization in patients with end-stage
coronary artery disease, 1663
Factors correlating with risk of mortality after
transmyocardial revascularization, 55
Implications of small vessel diameter in patients
undergoing percutaneous coronary
revascularization, 40
Improvement of left ventricular ejection fraction,
heart failure symptoms and prognosis
after revascularization in patients with chronic
coronary artery disease and viable myocardium
detected by dobutamine stress
echocardiography, 163
Long-term (three-year) prognosis of patients
treated with reperfusion or conservatively after
myocardial infarction, 70
Pravastatin prevents clinical events in revascularized
patients with average cholesterol concentrations,
106
Prediction of functional recovery of viable
myocardium after delayed revascularization in
postinfarction patients: accuracy of
dobutamine stress echocardiography and
influence of long-term vessel patency, 1012
Prognostic importance of lower extremity arterial
disease in patients undergoing coronary
revascularization in the Bypass Angioplasty
Revascularization Investigation (BARI), 716
Relationship of extent of revascularization with
angina at one year in the Bypass Angioplasty
Revascularization Investigation (BARI), 1750
Tunnel at the end of the light (editorial comment),
1671
Risk factors
Assessment of cardiovascular risk by use of
multiple-risk-factor assessment equations: A
Statement for Healthcare Professionals from
The American Heart Association and The
American College of Cardiology, 1348
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Lack of association of a common polymorphism of
the plasminogen activator inhibitor-1 gene
with coronary artery disease and myocardial
infarction, 1778
Racial differences in the significance of coronary
calcium in asymptomatic black and white
subjects with coronary risk factors, 787
Shocks as predictors of survival in patients with
transplantable cardioverter-defibrillators, 204
Smokeless tobacco as a possible risk factor for
myocardial infarction: a population-based
study in middle-aged men, 1784
Snuff, nicotine and cardiovascular disease:
implications for tobacco control (editorial
comment), 1791
ST-segment monitoring with continuous 12-lead
ECG improves risk stratification in patients
with chest pain and ECG nondiagnostic of
acute myocardial infarction, 1413
Sulfonylurea drugs and cardiovascular mortality
(letter), 958
Validation of risk adjustment models for in-hospital
percutaneous transluminal coronary
angioplasty mortality on an independent data
set, 692
Worse clinical outcome but similar graft patency in
women versus men in year after coronary
artery bypass surgery owing to an excess of
exposed risk factors in women, 1760
Rupture
See Myocardial rupture
Salvage procedures
Myocardial salvage: AT1-receptor blockade, AT2-
receptor activation and coronary collaterals
(letter), 310
Saphenous vein
Arterialization of human vein grafts is associated
with tenascin-C expression, 871
Retrieval and analysis of particulate debris after
saphenous vein graft intervention, 468
Sarcoplasmic reticulum
Alterations in cardiac sarcoplasmic reticulum Ca21
regulatory protein in the atrial tissue of
patients with atrial fibrillation, 255
Seasonal variation
Winter and cardiovascular mortality (letter), 2150
Serotonin
Vascular smooth muscle proliferation: synergistic
interaction between serotonin and low density
lipoproteins, 1644
Sestamibi
See Technetium-99m
Shock therapy
Shocks as predictors of survival in patients with
transplantable cardioverter-defibrillators, 204
Shunting
Transthoracic echocardiography using second
harmonic imaging: diagnostic alternative to
transesophageal echocardiography for the
detection of atrial right to left shunt in
patients with cerebral embolic events, 1823
Validation of the accuracy of both right and left
ventricular outflow volume determination and
semiautomated calculation of shunt volumes
through the atrial septal defects by digital
color Doppler flow mapping in a chronic
animal model, 587
Simvastatin
Additive effects of simvastatin and hormone
replacement therapy in hypercholesterolemic
postmenopausal women (letter), 311
Sinus node
Sinus node function and ventricular repolarization
during exercise stress test in long QT
syndrome patients with KvLQT1 and HERG
potassium channel defects, 823
Sinus rhythm
Exaggerated QT prolongation after cardioversion of
atrial fibrillation, 396
Skeletal muscle
Effect of aspirin and ifetroban on skeletal muscle
blood flow in patients with congestive heart
failure treated with enalapril, 170
Sleep apnea
Nocturnal ischemic events in patients with
obstructive sleep apnea syndrome and isch-
emic heart disease: effect of continuous
positive air pressure treatment, 1744
Slide preparation
President’s page: meeting improvement: a guide to
preparation of “slides” for presentation, 887
Smoking
Association of endotoxemia with carotid
atherosclerosis and cardiovascular disease:
prospective results from the Bruneck study,
1975
Hormone replacement therapy in postmenopausal
women protects against smoking-induced
changes in vascular structure and function,
131
Postmenopausal hormone therapy—good for
smokers? (editorial comment), 138
Smokeless tobacco as a possible risk factor for
myocardial infarction: a population-based
study in middle-aged men, 1784
Smooth muscle cells
External beam radiation after stent implantation
increases neointimal hyperplasia by
augmenting smooth muscle cell proliferation
and extracellular matrix accumulation, 561
Vascular smooth muscle proliferation: synergistic
interaction between serotonin and low density
lipoproteins, 1644
Snuff
Smokeless tobacco as a possible risk factor for
myocardial infarction: a population-based
study in middle-aged men, 1784
Snuff, nicotine and cardiovascular disease:
implications for tobacco control (editorial
comment), 1791
Sodium
Enhanced activity of sodium-lithium
countertransport in patients with cardiac
syndrome X: a potential link between cardiac
and metabolic syndrome X (letter), 955
Sotalol
Oral d,l sotalol reduces the incidence of
postoperative atrial fibrillation in coronary
artery bypass surgery patients: a randomized,
double-blind, placebo-controlled study, 334
Spasm
See coronary artery spasm
ST segment
Acute myocardial infarction with isolated ST-
segment elevation in posterior chest leads
V7–9: “hidden” ST-segment elevations
revealing acute posterior infarction, 748
Significance of persistent ST elevation versus early
resolution of ST segment elevation after
primary PTCA, 1932
ST elevation secondary to microvascular dysfunction
(letter), 312
ST-segment monitoring with continuous 12-lead
ECG improves risk stratification in patients
with chest pain and ECG nondiagnostic of
acute myocardial infarction, 1413
Stenosis
See also Restenosis
One-year follow-up after intravascular ultrasound
assessment of moderate left main coronary
artery disease in patients with ambiguous
angiograms, 707
Repeated stunning precedes myocardial hibernation
in progressive multiple coronary artery
obstruction, 2126
Stenting
Acute and nine-month clinical outcomes after
“suboptimal” coronary stenting: results from
the STent Anti-thrombotic Regimen Study
(STARS), 698
Can stents damage coronary arteries remote from
the stent? (editorial comment), 1680
Clopidogrel an an adjunctive antiplatelet therapy
during coronary stenting, 1884
Clopidogrel versus ticlopidine after intracoronary
stent placement, 1891
Direct coronary stenting without predilation, 1916
Does angiography six months after coronary
intervention influence management and
outcome?, 1507
Early recovery of coronary flow reserve after stent
implantation as assessed by positron emission
tomography, 1036
External beam radiation after stent implantation
increases neointimal hyperplasia by
augmenting smooth muscle cell proliferation
and extracellular matrix accumulation, 561
Final results of the STent versus Directional
Coronary Atherectomy Randomized Trial
(START), 1050
Hemodynamic and physical performance during
maximal exercise in patients with an aortic
bioprosthetic valve: comparison of stentless
versus stented bioprosthesis, 1609
Hyperemic coronary flow after optimized
intravascular ultrasound-guided balloon
angioplasty and stent implantation, 1899
Laser angioplasty of restenosed coronary stents:
results of a multicenter surveillance trial, 25
Long lesions, long stents and the long process of
stent optimization (editorial comment), 660
Long-term endothelial dysfunction after coronary
artery stenting, 1675
Mechanisms of acute lumen gain and recurrent re-
stenosis after rotational atherectomy of diffuse
in-stent restenosis: a quantitative angiographic
and intravascular ultrasound study, 33
Nuclear cardiology after angioplasty and stent
placement: beyond sensitivity and specificity
(editorial comment), 1042
Optimal balloon angioplasty versus elective stent
implantation (editorial comment), 1907
Periprocedural quantitative coronary angiography
after Palmaz-Schatz stent implantation
predicts the restenosis rate at six months:
results of a metaanalysis of the Belgian
Netherlands Stent Study (BENESTENT) I,
BENESTENT II Pilot, BENESTENT II
and MUSIC Trials, 1067
Propensity and mechanisms of restenosis in
different coronary stent designs:
complementary value of the analysis of the
luminal gain-loss relationship, 1490
Randomized comparison of coronary stent
implantation and balloon angioplasty in the
treatment of de novo coronary artery lesions
(START): a four-year follow-up, 1498
Randomized trial of elective stenting after balloon
recanalization of chronic total occlusions, 722
Short- and long-term evolution of unstented
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nonocclusive coronary dissection after
coronary angioplasty, 1484
Stented segment length as an independent predictor
of restenosis, 651
To stent or not to stent—that is the question
(editorial comment), 1489
Use of clopidogrel in coronary stenting: what was
the question? (editorial comment), 1895
Vascular radiation therapy: the devil is in the dose
(editorial comment), 567
When should we start randomized trials for new
devices? (editorial comment), 1049
Streptokinase
Recombinant hirudin (lepirudin) for the
improvement of thrombolysis with
streptokinase in patients with acute
myocardial infarction: results of the HIT-4
trial, 966
Survival 12 years after randomization to
streptokinase: the influence of Thrombolysis
in Myocardial Infarction flow at three to four
weeks, 62
Streptozotocin
Abnormal cardiac function in the streptozotocin-
induced non–insulin-dependent diabetic rat:
noninvasive assessment with Doppler
echocardiography and contribution of the
nitric oxide pathway, 2110
Stress testing
See also Dipyridamole; Dobutamine; Thallium-201
studies
Comparison of stress/rest myocardial perfusion
tomography, dipyridamole and dobutamine
stress echocardiography for the detection of
coronary disease in hypertensive patients with
chest pain and positive exercise test, 441
Delayed systolic blood pressure recovery after
graded exercise: an independent correlate of
angiographic coronary artery disease, 754
European multicenter study on propionyl-L-
carnitine in intermittent claudication, 1618
Familial polymorphic ventricular arrhythmias: a
quarter century of successful medical
treatment based on serial exercise-
pharmacologic testing, 2015
Hemodynamic and physical performance during
maximal exercise in patients with an aortic
bioprosthetic valve: comparison of stentless
versus stented bioprosthesis, 1609
Impact of early ventricular unloading on exercise
performance in preadolescents with single
ventricle Fontan physiology, 1637
Increased stress right ventricular activity on dual
isotope perfusion SPECT: a sign of
multivessel and/or left main coronary artery
disease, 420
Incremental value of prognostic testing in patients
with known or suspected ischemic heart
disease: a basis for optimal utilization of
exercise technetium-99m sestamibi myocardial
perfusion single-photon emission computed
tomography (historical review), 9
Low-level exercise echocardiography detects
contractile reserve and predicts reversible
dysfunction after acute myocardial infarction:
comparison with low-dose dobutamine
echocardiography, 989
Pulmonary hypertension and exercise intolerance in
patients with heart failure, 1802
Sinus node function and ventricular repolarization
during exercise stress test in long QT
syndrome patients with KvLQT1 and HERG
potassium channel defects, 823
Slowed glycogen utilization enhances exercise
endurance in patients with heart failure, 1807
Stress-velocity relationship
Influence of low afterload on the nature of the
stress-velocity relationship, 1219
Stroke
Winter and cardiovascular mortality (letter), 2150
Stunning
Cardiomyocytes from hearts with left ventricular
dysfunction after ischemia-reperfusion do not
manifest contractile abnormalities, 594
Cellular and extracellular mechanisms causing
myocardial stunning (editorial comment), 603
Myocardial perfusion and oxygen consumption in
reperfused noninfarcted dysfunctional
myocardium after unstable angina: direct
evidence for myocardial stunning in humans,
1939
Repeated stunning precedes myocardial hibernation
in progressive multiple coronary artery
obstruction, 2126
Sudden death
Management of ventricular arrhythmias: a trial-
based approach, 621
Sudden death, arrhythmic events and measurement
of heart rate variability (letter), 2148
Sudden death in mitral regurgitation: why was I so
surprised? (editorial comment), 2086
Sudden death in mitral regurgitation due to flail
leaflet, 2078
Sulfonylurea drugs
Sulfonylurea drugs and cardiovascular mortality
(letter), 958
Superoxide
Differential effects of a- and g-tocopherol on low-
density lipoprotein oxidation, superoxide
activity, platelet aggregation and arterial
thrombogenesis, 1208
Surgery, cardiac
Atrial arrhythmias after cardiac surgery: Sisyphus
revisited? (editorial comment), 348
Intravenous amiodarone for the prevention of atrial
fibrillation after open heart surgery: the
Amiodarone Reduction in Coronary Heart
(ARCH) trial, 343
Ventricular reduction therapy: controlled clinical
trials overdue (letter), 610
Surgery, cardiothoracic
Training programs in the United States, in adult
cardiology, pediatric cardiology, and
cardiothoracic surgery, and post-fellowship
training (Preceptorships) in adult cardiology,
1231
Surgery, coronary artery bypass
See also Grafts
ACC/AHA Guidelines for Coronary artery bypass
graft surgery: A Report of the American
College of Cardiology/American Heart
Association Task Force on Practice
Guidelines (Committee to Revise the 1991
Guidelines for Coronary Artery Bypass Graft
Surgery), 1262
Changing outcomes in percutaneous coronary
interventions: a study of 34,752 procedures in
northern New England, 674
Chlamydia pneumoniae in redo and first-time
coronary artery bypass grafting (letter), 953
Effects of coronary artery bypass grafting using
internal mammary arteries for diabetic
patients, 532
Oral d,l sotalol reduces the incidence of
postoperative atrial fibrillation in coronary
artery bypass surgery patients: a randomized,
double-blind, placebo-controlled study, 334
Prevention of postoperative atrial fibrillation: what
is the best approach? (editorial comment), 340
Relationship of extent of revascularization with
angina at one year in the Bypass Angioplasty
Revascularization Investigation (BARI), 1750
Worse clinical outcome but similar graft patency in
women versus men in year after coronary
artery bypass surgery owing to an excess of
exposed risk factors in women, 1760
Surgery, pediatric
Factors associated with outcomes of persistent
truncus arteriosus, 545
Is it necessary to routinely fenestrate an extracardiac
Fontan?, 539
New strategy for the surgical treatment of aortic
coarctation associated with ventricular septal
defect in infants using an absorbable
pulmonary artery band, 866
Repairing tetralogy of Fallot—does age matter?
(letter), 1657
Surgery, valve
See also Valvuloplasty
Echocardiographic predictors of left ventricular
outflow tract obstruction and systolic anterior
motion of the mitral valve after mitral valve
reconstruction for myxomatous valve disease,
2096
Survival rates
In-hospital versus out-of-hospital presentation of
life-threatening ventricular arrhythmias
predicts survival: results from the AVID
Registry, 1111
Survival 12 years after randomization to
streptokinase: the influence of thrombolysis in
myocardial infarction flow at three to four
weeks, 62
Symposia
President’s page: ACC Annual Scientific Session—
a new meeting for a new millennium, 1655
Syncope
Diagnostic utility of mechanical, pharmacological
and orthostatic stimulation of the carotid
sinus in patients with unexplained syncope,
1587
Implantable defibrillator event rates in patients with
unexplained syncope and inducible sustained
ventricular tachyarrhythmias: a comparison
with patients known to have sustained
ventricular tachycardia, 2023
Long-term outcome of patients with unexplained
syncope treated with an electrophysiologic-
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